These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 26491321

  • 1. Development of polymer-bound fast-dissolving metformin buccal film with disintegrants.
    Haque SE, Sheela A.
    Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):199-205. PubMed ID: 26491321
    [Abstract] [Full Text] [Related]

  • 2. Transmucosal delivery of metformin- a comprehensive study.
    Sushma M, Raju YP, Sundaresan CR, Vandana KR, Kumar NV, Chowdary VH.
    Curr Drug Deliv; 2014; 11(2):172-8. PubMed ID: 23848354
    [Abstract] [Full Text] [Related]

  • 3. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK, Kołodziejska J, Zgoda MM.
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [Abstract] [Full Text] [Related]

  • 4. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A, Dudhedia M, Deng W, Shepard K, Zhong L, Povilaitis E, Zimny E.
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [Abstract] [Full Text] [Related]

  • 5. Functional assessment of four types of disintegrants and their effect on the spironolactone release properties.
    Rojas J, Guisao S, Ruge V.
    AAPS PharmSciTech; 2012 Dec; 13(4):1054-62. PubMed ID: 22899380
    [Abstract] [Full Text] [Related]

  • 6. Influence of disintegrants in different substrate physical form on dimensional recovery of multi-component tablet.
    Sarkar S, Ooi SM, Liew CV, Tan BX, Heng PW.
    Int J Pharm; 2014 Nov 20; 475(1-2):558-65. PubMed ID: 25218488
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of a novel superdisintegrant by starch derivatization with polysuccinimide and its application for the development of Ondansetron fast dissolving tablet.
    Sadeghi M, Hemmati S, Hamishehkar H.
    Drug Dev Ind Pharm; 2016 Nov 20; 42(5):769-75. PubMed ID: 26289005
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Formulation and Evaluation of Oral Dissolving Films of Amlodipine Besylate Using Blends of Starches With Hydroxypropyl Methyl Cellulose.
    Ayorinde JO, Odeniyi MA, Balogun-Agbaje O.
    Polim Med; 2016 Nov 20; 46(1):45-51. PubMed ID: 28397418
    [Abstract] [Full Text] [Related]

  • 10. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
    Zaheer K, Langguth P.
    Drug Dev Ind Pharm; 2018 Mar 20; 44(3):444-451. PubMed ID: 29098885
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of disintegrants functionality for orodispersible mini tablets.
    Soulairol I, Chaheen M, Tarlier N, Aubert A, Bataille B, Sharkawi T.
    Drug Dev Ind Pharm; 2017 Nov 20; 43(11):1770-1779. PubMed ID: 28581832
    [Abstract] [Full Text] [Related]

  • 12. Gastroretentive drug delivery of metformin hydrochloride: formulation and in vitro evaluation using 3(2) full factorial design.
    Boldhane SP, Kuchekar BS.
    Curr Drug Deliv; 2009 Oct 20; 6(5):477-85. PubMed ID: 19863493
    [Abstract] [Full Text] [Related]

  • 13. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
    Obaidat AA, Obaidat RM.
    Acta Pharm; 2011 Mar 20; 61(1):83-91. PubMed ID: 21406346
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Curcumin- β-Cyclodextrin Molecular Inclusion Complex: A Water-Soluble Complex in Fast-dissolving Tablets for the Treatment ofNeurodegenerative Disorders.
    Mugundhan SL, Balasubramaniyan P, Narayanasamy D, Mohan M.
    Pharm Nanotechnol; 2024 Mar 20; 12(4):365-377. PubMed ID: 38192139
    [Abstract] [Full Text] [Related]

  • 17. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY, Lin KH, Li MJ.
    J Pharm Sci; 2002 Sep 20; 91(9):2040-6. PubMed ID: 12210050
    [Abstract] [Full Text] [Related]

  • 18. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK, Fahmy SA, Galeel OW.
    Pak J Pharm Sci; 2012 Oct 20; 25(4):815-22. PubMed ID: 23009999
    [Abstract] [Full Text] [Related]

  • 19. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S, De Beer T, Remon JP, Vervaet C.
    Int J Pharm; 2012 Jan 17; 422(1-2):310-7. PubMed ID: 22101283
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization.
    Souto C, Rodríguez A, Parajes S, Martínez-Pacheco R.
    Eur J Pharm Biopharm; 2005 Sep 17; 61(1-2):94-9. PubMed ID: 15967651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.